Head‐to‐head comparison of leading blood tests for Alzheimer's disease pathology

Plasma p-tau217 measures most accurately classified amyloid and tau status. Plasma Aβ42/Aβ40 had relatively low accuracy in classification of amyloid status. Plasma p-tau217 measures had higher correlations with cortical thickness than NfL. Correlations of plasma biomarkers with dementia symptoms were relatively low.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2024-10-12
DOI
https://doi.org/10.1002/alz.14315
Citations
123
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
47.43

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Head‐to‐head comparison of leading blood tests for Alzheimer's disease pathology

Benjamin Saef, Michael V. Baratta, Duygu Tosun, Nicholas James Ashton et al.
123 citations
Alzheimer s & Dementia
Dementia and Cognitive Impairment Research
47.43
article

Head‐to‐head comparison of leading blood tests for Alzheimer's disease pathology

Benjamin Saef, Michael V. Baratta, Duygu Tosun, Nicholas James Ashton, Anthony W. Bannon, David Raunig, Kyle Ferber, Janaky Coomaraswamy, Yulia Mordashova, Jeffrey L. Dage, Erin G. Rosenbaugh, Carrie E. Rubel, Gallen Triana‐Baltzer, Kellen K. Petersen, Emily A. Meyers, Suzanne E. Schindler, Henrik Zetterberg, Yan Li, Leslie M. Shaw, William Z. Potter, Ziad S. Saad, Lei Du‐Cuny
article en
123 citations

Abstract

Plasma p-tau217 measures most accurately classified amyloid and tau status. Plasma Aβ42/Aβ40 had relatively low accuracy in classification of amyloid status. Plasma p-tau217 measures had higher correlations with cortical thickness than NfL. Correlations of plasma biomarkers with dementia symptoms were relatively low.

Alzheimer s & DementiaVol. 20(11)
Alzheimer's Association (US), Biogen (United States) (US), Johnson & Johnson (United States) (US), University of Wisconsin–Madison (US), University of California, San Francisco (US), Washington University in St. Louis (US), Foundation for the National Institutes of Health (US), Sahlgrenska University Hospital (SE), University of California System (US), AbbVie (United States) (US), UK Dementia Research Institute (GB), AbbVie (Germany) (DE), Takeda (United States) (US), Banner Sun Health Research Institute (US), National Hospital for Neurology and Neurosurgery (GB), Banner Alzheimer’s Institute, Indiana University School of Medicine, University College London (GB), Indiana University – Purdue University Indianapolis (US), University of Pennsylvania (US), University of Gothenburg (SE)
Foundation for the National Institutes of Health, Alzheimer's Association, Alzheimer's Drug Discovery Foundation, Biogen, AbbVie, Takeda Pharmaceutical Company, National Institutes of Health, National Institute on Aging, Janssen Research and Development
Good health and well-being
Openalex Percentile: Top 0%
Dementia and Cognitive Impairment Research
47.43
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.